PLAN B ONE-STEP OTC
Generic Name and Formulations:
Levonorgestrel 1.5mg; tabs.
Indications for PLAN B ONE-STEP:
Prevention of pregnancy after known or suspected contraceptive failure or unprotected intercourse. Not for use as regular contraceptive.
Rule out pregnancy first. Take one single-dose as soon as possible but no later than 72hrs after unprotected intercourse. If vomiting occurs within 2hrs, may consider repeating dose.
See full labeling. Known or suspected pregnancy.
See full labeling. Ectopic pregnancy. Does not protect against HIV or other STDs.
May be antagonized by CYP3A4 inducers (eg, efavirenz, rifampin, barbiturates, carbamazepine, phenytoin, St. John's wort).
Heavier menstrual bleeding, nausea, vomiting, abdominal pain, fatigue, headache, dizziness, breast tenderness, delay of menses (>7days).
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Examining the Efficacy of Different Oxygen Flow Rates for Cluster Headache Attacks
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- Daily Alcohol Use May Drive Chronic Pain in Adults With HIV
- Tools to Address the Opioid Crisis
- AHA/ACC Release Updated Guidelines for Cholesterol Management
- Women Fed Soy Formula as Infants More Likely to Experience Menstrual Pain